Stock research

OTLK Outlook Therapeutics, Inc.

Healthcare • Biotechnology

$0.91
-0.06 (—%)

Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical development, focused on inventing and bringing to market monoclonal antibody treatments for various eye conditions. Its...…

ALL change

-97.93%

Range high

$55.20

Congress · 90d

0

Insiders · 90d

0

Public signal layer

Who is disclosing activity in OTLK?

Latest linked filings in Indy

Congress

View all

No linked Congress trades yet.

Corporate insiders

View all

No insider transactions yet.

Price

Hover to inspect price

Showing ALL history. Source: FMP historical price full.

Prev Close
$0.98
Day High
$0.98
Day Low
$0.90
52w High
$3.39
52w Low
$0.16
Volume
5,888,521
Avg Volume
Beta
0.781

* TTM/most recent where available

Company

Ticker
OTLK
Exchange
Sector
Healthcare
Industry
Biotechnology
Country
US
CEO
Robert Charles Jahr
Employees
17
Website
www.outlooktherapeutics.com

Key Metrics

Market Cap
37.6M
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available

DCF Valuation

↑ Above DCF 35.9%

Standard DCF

$0.67 as of Aug. 3, 2026

Levered DCF

-$0.11 as of Aug. 3, 2026

Market Price

$0.91 vs DCF 35.9%

DCF vs Price (30D window)

Price uses last 30 days; DCF line holds latest value across the window.

DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).